Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2841-2850 of 10948

Edit search filters
  1. Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients with Brain Metastases that have been Removed by Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Alisertib in Treating Young Patients with Recurrent or Refractory Solid Tumors or Leukemia

  3. Individualized Preoperative Rehabilitation Pilot

  4. Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice

    Rochester, MN

  5. A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

    Jacksonville, FL, Rochester, MN

  6. Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim 3)

    Rochester, MN

  7. Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)

    Rochester, MN

  8. Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)

    Rochester, MN

  9. Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients

    Rochester, MN

  10. Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

    Rochester, MN

.

Mayo Clinic Footer